Trends in the likelihood of receiving percutaneous coronary intervention in a low-volume hospital and disparities by sociodemographic communities.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 07 10 2022
accepted: 17 12 2022
entrez: 18 1 2023
pubmed: 19 1 2023
medline: 21 1 2023
Statut: epublish

Résumé

Over the past two decades, percutaneous coronary intervention (PCI) capacity has increased while coronary artery disease has decreased, potentially lowering per-hospital PCI volumes, which is associated with less favorable patient outcomes. Trends in the likelihood of receiving PCI in a low-volume center have not been well-documented, and it is unknown whether certain socioeconomic factors are associated with a greater risk of PCI in a low-volume facility. Our study aims to determine the likelihood of being treated in a low-volume PCI center over time and if this likelihood differs by sociodemographic factors. We conducted a retrospective cohort study of 374,066 hospitalized patients in California receiving PCI from January 1, 2010, to December 31, 2018. Our primary outcome was the likelihood of PCI discharges at a low-volume hospital (<150 PCI/year), and secondary outcomes included whether this likelihood varied across different sociodemographic groups and across low-volume hospitals stratified by high or low ZIP code median income. The proportion of PCI discharges from low-volume hospitals increased from 5.4% to 11.0% over the study period. Patients of all sociodemographic groups considered were more likely to visit low-volume hospitals over time (P<0.001). Latinx patients were more likely to receive PCI at a low-volume hospital compared with non-Latinx White in 2010 with a 166% higher gap in 2018 (unadjusted proportions). The gaps in relative risk (RR) between Black, Latinx and Asian patients versus non-Latinx white increased over time, whereas the gap between private versus public/no insurance, and high versus low income decreased (interaction P<0.001). In low-income ZIP codes, patients with Medicaid were less likely to visit low-volume hospitals than patients with private insurance in 2010; however, this gap reversed and increased by 500% in 2018. Patients with low income were more likely to receive PCI at low-volume hospitals relative to patients with high income in all study years. The likelihood of receiving PCI at low-volume hospitals has increased across all race/ethnicity, insurance, and income groups over time; however, this increase has not occurred evenly across all sociodemographic groups.

Identifiants

pubmed: 36652416
doi: 10.1371/journal.pone.0279905
pii: PONE-D-22-27766
pmc: PMC9847957
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0279905

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL114822
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL134182
Pays : United States

Informations de copyright

Copyright: © 2023 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Circ Cardiovasc Interv. 2016 Mar;9(3):e003699
pubmed: 26957419
J Am Coll Cardiol. 2017 May 2;69(17):2212-2241
pubmed: 28291663
J Thorac Cardiovasc Surg. 2005 Jun;129(6):1276-82
pubmed: 15942567
J Thorac Cardiovasc Surg. 2009 Nov;138(5):1100-7
pubmed: 19837215
Resuscitation. 2008 Dec;79(3):417-23
pubmed: 18951678
PLoS One. 2016 May 12;11(5):e0154535
pubmed: 27171406
JAMA Cardiol. 2016 Jun 1;1(3):255-65
pubmed: 27438103
Am J Cardiol. 2014 Oct 1;114(7):1003-10
pubmed: 25118124
JAMA Cardiol. 2018 Nov 1;3(11):1041-1049
pubmed: 30267035
J Am Heart Assoc. 2013 Oct 28;2(6):e000370
pubmed: 24166491
JAMA Intern Med. 2020 Mar 1;180(3):357-366
pubmed: 31738826
Circ Cardiovasc Qual Outcomes. 2017 Aug;10(8):
pubmed: 28794119
JACC Cardiovasc Interv. 2017 Aug 14;10(15):1475-1485
pubmed: 28797422
Can J Cardiol. 2016 Aug;32(8):987.e25-31
pubmed: 27177835
Circ Cardiovasc Qual Outcomes. 2013 Jul;6(4):400-8
pubmed: 23838110
JACC Cardiovasc Interv. 2017 May 8;10(9):918-927
pubmed: 28473114
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):247-250
pubmed: 28963782
N Engl J Med. 1999 Oct 28;341(18):1359-67
pubmed: 10536129
BMJ. 2014 Jan 24;348:f7450
pubmed: 24464277
J Am Coll Cardiol. 2013 Jul 23;62(4):357-96
pubmed: 23665367
Circ Cardiovasc Interv. 2016 Mar;9(3):e003070
pubmed: 26957417
J Am Heart Assoc. 2020 May 5;9(9):e015404
pubmed: 32347146
Cardiovasc Diagn Ther. 2019 Feb;9(1):18-29
pubmed: 30881873
JAMA Netw Open. 2018 Nov 2;1(7):e184240
pubmed: 30646346
JAMA Netw Open. 2018 Nov 2;1(7):e185202
pubmed: 30646394
Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e004971
pubmed: 30606054
Am J Public Health. 2001 Jul;91(7):1082-8
pubmed: 11441735
JAMA. 2012 Oct 10;308(14):1460-8
pubmed: 23047360
Int J Cardiol. 2019 Oct 15;293:91-100
pubmed: 31104824
JAMA. 2015 Nov 17;314(19):2045-53
pubmed: 26551163
J Am Heart Assoc. 2017 Sep 22;6(9):
pubmed: 28939713
JAMA Netw Open. 2020 Feb 5;3(2):e1921326
pubmed: 32058558
Circ Cardiovasc Qual Outcomes. 2013 Nov;6(6):659-67
pubmed: 24192572
Health Serv Res. 2016 Apr;51(2):592-609
pubmed: 26174998
Curr Cardiol Rev. 2015;11(3):238-45
pubmed: 25418513
J Am Heart Assoc. 2020 Jun 2;9(11):e016853
pubmed: 32458708
Ann Thorac Surg. 2019 Nov;108(5):1404-1408
pubmed: 31039350
Circulation. 2019 Jan 22;139(4):458-472
pubmed: 30586696
CMAJ. 2011 Oct 18;183(15):1705-12
pubmed: 21911550

Auteurs

Christina Wang (C)

Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.

Karla Lindquist (K)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America.

Harlan Krumholz (H)

Department of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.

Renee Y Hsia (RY)

Department of Emergency Medicine, University of California San Francisco, San Francisco, California, United States of America.
Philip R. Lee Institute for Health Policy Studies, University of California San Francisco, San Francisco, California, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH